Investing Profile
Andrew Bayliffe
Your Intro Paths to Andrew Bayliffe
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Andrew Bayliffe on
cbAndrew Bayliffe is on these Sector & Stage Rankings
Medical Devices (Series A)Pharmaceuticals (Series A)BioTech (Series A)Digital Health (Series A)LondonHealth & Hospital Services (Series A)Health IT (Series A)Medical Devices (Series A)Pharmaceuticals (Series A)BioTech (Series A)Digital Health (Series A)Health & Hospital Services (Series A)Health IT (Series A)
Andrew Bayliffe's Experience
Chief Scientific Officer Marengo Therapeutics2020 - Present
Venture Partner Apple Tree Partners2019 - Present
Head, Respiratory and Inflammation Research Unit GSK2015 - 2020
Global Development Leader - Respiratory & Inflammation GSK2013 - 2015
Head, Translational Medicine - Biopharmaceuticals Innovation Unit GSK2011 - 2013
Clinical Pharmacology Leader - Biopharmaceuticals R&D GSK2008 - 2011
Clinical Pharmacology Leader - Immunology & Inflammation R&D GSK2004 - 2008
Translational Scientist - Clinical Pharmacology & Experimental Medicine GSK2002 - 2004
Research Scientist, Pharmacogenetics & Applied Diagnostics GSK2000 - 2002
Research Scientist AstraZeneca1998 - 2000
Andrew Bayliffe's Education
University of Leeds Doctor of Philosophy - PhD Pharmacology and Molecular Biology
The Manchester Metropolitan University Bachelor of Science - BS Pharmacology